GLP-1-Agonists combined with Basal Insulin in the Treatment of Type 2 Diabetes mellitus

被引：0
|
作者：
Pavlicek, V. [1 ]
机构：
[1] Kantonsspital Munsterlingen, Med Klin, CH-8596 Munsterlingen, Switzerland
来源：
DIABETOLOGE | 2014年 / 10卷 / 08期
关键词：
D O I：
10.1007/s11428-014-1317-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：662 / 663
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review
    Cimmaruta, D.
    Maiorino, M. I.
    Scavone, C.
    Sportiello, L.
    Rossi, F.
    Giugliano, D.
    Esposito, K.
    Capuano, A.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 : 77 - 83
  • [22] GLP-1 receptor agonists and cirrhosis risk in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGIE, 2024, 20 (08): : 897 - 898
  • [23] Evaluating the Response to GLP-1 Agonists in Veterans with Type 2 Diabetes Mellitus
    Begley, Brett A.
    Desouza, Cyrus
    Shivaswamy, Vijay
    Samson, Kaeli
    Silverman, Emily
    DIABETES, 2021, 70
  • [24] NUTRITIONAL INSULIN OR GLP-1 RECEPTOR AGONIST: CROSSROADS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
    Garg, Rajesh
    ENDOCRINE PRACTICE, 2017, 23 (11) : 1357 - 1358
  • [25] Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
    Yehuda Handelsman
    Marcel H. A. Muskiet
    Graydon S. Meneilly
    Advances in Therapy, 2020, 37 : 973 - 973
  • [26] Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
    Bruno Detournay
    Zahra Boultif
    Amar Bahloul
    Viviane Jeanbat
    Julien Robert
    PharmacoEconomics - Open, 2021, 5 : 211 - 219
  • [27] Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
    Detournay, Bruno
    Boultif, Zahra
    Bahloul, Amar
    Jeanbat, Viviane
    Robert, Julien
    PHARMACOECONOMICS-OPEN, 2021, 5 (02) : 211 - 219
  • [28] Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
    Nauck, Michael A.
    Meier, Juris J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (06) : R211 - R234
  • [29] Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison
    Jung, Han Na
    Cho, Yun Kyung
    Min, Se Hee
    Kim, Hwi Seung
    Kim, Ye-Jee
    Park, Joong-Yeol
    Lee, Woo Je
    Jung, Chang Hee
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [30] A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment
    Tobaiqy, Mansour
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 981 - 990
12345